Articles tagged with Rheumatology
A recent study identified factors that increase the risk of falls among orthopedic inpatients, particularly those undergoing total hip replacements. The study found that THR patients are more likely to have serious falls earlier in their stay, highlighting the need for close monitoring and vigilance.
Researchers identified advanced stage cancer as the key factor predicting joint pain in breast cancer patients on aromatase inhibitor therapy. The study also found that tenosynovitis, inflammation of tendon sheaths, was present in some symptomatic subjects, but no correlation with depression or autoimmune markers was observed.
Researchers present advances in preventing falls in orthopedic patients, improving quality of life in children with lupus, and understanding joint pain caused by breast cancer medication. The hospital also recognizes three faculty members as masters at the American College of Rheumatology Annual Meeting.
Researchers found that etanercept treatment significantly increased mean height, weight, and body mass index (BMI) percentiles in patients with juvenile idiopathic arthritis (JIA). Growth improvements were observed in both etanercept alone and combined with methotrexate treatments.
Research by Imperial College London and UCSF suggests that anti-inflammatory drugs could help prevent cognitive problems after surgery. The study found that a specific inflammatory response in the brain triggers memory loss, and targeting this response with TNF inhibitors may be an effective treatment approach.
Research from Utrecht University reveals that anger and sadness amplify pain equally in both women with and without fibromyalgia. The study also found that emotional sensitization of pain may be especially detrimental in people who already have high pain levels.
The American College of Rheumatology has announced revised classification criteria for rheumatoid arthritis, allowing researchers to study patients earlier in the course of the disease. The new criteria aim to prevent joint damage and improve patient outcomes.
A new study published in Rheumatology found that moderate alcohol consumption may reduce the severity of rheumatoid arthritis symptoms and risk. The study, which involved over 1,800 patients, showed a significant inverse association between frequency of alcohol consumption and RA severity.
Researchers found that regular aerobic exercise improves function, lessens joint pain, and increases quality of life in patients with stable rheumatoid arthritis. The study analyzed 14 studies and meta-analysis included 510 patients, showing that cardio-respiratory conditioning is safe and beneficial for this group.
A study of 356 RA patients found that achieving disease remission leads to significant improvements in work productivity, quality of life, and physical functioning compared to low disease activity. Longitudinal analysis over one year showed stable emotional aspects and significant reductions in overall activity impairment.
Patients with concurrent anemia, lymphocytopenia, or hypocomplementemia are more likely to develop lymphoma and experience increased mortality due to pulmonary and hepatic involvement. The study found that liver and lung involvement and non-Hodgkin lymphoma development were also related to an increased mortality in pSS patients.
A new study found that SLE patients from Northern Europe tend to have photosensitivity, while those from Southern Europe experience more arthritis. The research highlights the impact of genetics on disease manifestations.
Studies from France and Brazil reveal that rheumatic conditions like RA and SLE significantly impact emotional relationships and sexual activity, with many patients unwilling to seek help. Patients often experience physical problems such as decreased libido and joint pain, as well as emotional consequences like guilt and frustration.
Two studies confirm vitamin D deficiency is prevalent among patients with rheumatic conditions, including RA and osteoporosis. Supplementation with recommended daily doses fails to normalize vitamin D levels, highlighting the need for further research on effective treatment strategies.
A new registry reveals key differences in Chinese SLE patients compared to those studied in the US, Europe, and Malaysia. Chinese patients are more likely to present with haematological disorders and kidney disease, but less likely to experience neurological manifestations.
Studies show smoking predicts RA diagnosis and poor response to anti-TNFs, altering gene expression and immune response. Swedish studies confirm smoking risk for RA, while mouse models reveal similar changes in human cells.
A multinational study has validated previous research showing NT-proBNP is a strong indicator for cardiovascular risk in arthritis patients. Early control of inflammation can help manage long-term CV risk associated with RA. Elevated inflammatory markers like CRP are also independent predictors of CV risk.
A new study found that alcohol consumption is associated with a reduced risk of developing several arthritic conditions. However, the exact nature of this association remains unclear, with some researchers suggesting that moderate alcohol consumption may protect against systemic inflammation.
A recent study found a significant rise in rheumatoid arthritis incidence among women between 1995 and 2007. Researchers attribute the increase to environmental factors such as vitamin D deficiency, cigarette smoking, and lower-dose synthetic estrogens in oral contraceptives.
A study found that nearly one-third of RA patients and their physicians disagreed on assessing the disease severity. The disagreement was most prevalent in patients with depressive symptoms or poor overall function.
Researchers found African-Americans were less likely to have a varus thrust but more likely to have a valgus thrust than Caucasians. This disparity may help explain differences in knee osteoarthritis (OA) involvement at the knee.
A study published in Arthritis Care & Research found that obesity and physical inactivity contribute to a higher prevalence of arthritis and activity limitations in the US compared to Canada. Women are particularly vulnerable, with a higher incidence of arthritis and activity limitations in both countries.
Researchers have identified a biomarker that can help predict which patients with rheumatoid arthritis are likely to benefit from therapy with TNF-antagonist drugs. The study found that patients with higher baseline levels of type I interferon and increased IFN-beta/alpha ratio were more likely to respond to therapy.
A recent US study reveals that pediatric patients with rheumatic diseases have significantly lower mortality rates compared to previous studies. The Childhood Arthritis and Rheumatology Research Alliance estimates that 300,000 children in the US suffer from some form of arthritis or rheumatic disease.
Researchers found that touch typing training significantly improved keyboarding speed in RA workers, regardless of impairment. However, impairments in hand function were associated with reduced mouse speeds, highlighting the need for effective strategies to maintain productivity in computer users with RA.
The study found that all three groups demonstrated improvements in physical function tests and decreased self-reported pain and disability. Self-management programs showed the highest compliance rates, leading researchers to suggest they may be an equally effective early treatment for knee OA.
A recent study found that increasing patient responsibility for medical decisions decreases their willingness to accept risky treatments. Patients who were presented with choices reported higher worry about risks and lower uptake of treatment.
A recent study published in the Journal of Rheumatology has found a clear link between smoking and skin problems in people with systemic lupus erythematosus (SLE). The study, led by Dr. Christian A Pineau, reveals that smokers are at higher risk for skin damage, including permanent hair loss and scarring from skin inflammation.
A comprehensive collection of 38 articles written by international experts provides a detailed overview of current rheumatology research. The resource covers basic, translational, and clinical research in rheumatology, offering clinicians and researchers a valuable reference work.
A new study found that 61.8% of AS patients showed substantial clinical benefit after 5 years on IFX therapy, including reduced arthritis and enthesitis. Patients who completed the trial demonstrated low disease activity, good functional status, and favorable spinal mobility.
Over half of people with rheumatoid arthritis also have periodontitis, displaying fewer teeth and higher disease activity. Anti-TNF therapy improves periodontal status in RA patients, suggesting a link between the two conditions. Periodontitis may be a risk factor for developing RA, especially in non-smokers.
A new multinational study found that RA individuals in lower GDP countries are more likely to keep working despite higher disease activity and functional disability scores. The probability of individuals continuing work for 2 years was 80%, while the probability of continuing to work for 5 years was 68%. This highlights the significant...
Rheumatology patients want more information and open dialogue about their sexual health with healthcare professionals, but face barriers due to nurse embarrassment. Nurses agree that patient-initiated conversations are preferable, but often hesitate to share their expertise.
Three studies confirm etanercept's effectiveness in treating JIA, with improved HRQoL and reduced disease activity. The treatment showed a good safety profile, with most patients experiencing mild adverse events.
A study found that 63% of RA patients suffer from psychiatric disorders, with the majority being in the depressive spectrum. Cognitive dysfunction and sleep disorders were also common among patients. Those with depression exhibited more severe RA symptoms, including pain and functional insufficiency.
A quarter of active RA patients on CP-690,550 (10mg and 15mg) achieved ACR70 at week 12. The study demonstrated dose-dependent efficacy and statistical superiority to placebo in nearly all clinical outcomes.
A new study found that childless women are diagnosed with chronic arthritides an average of 5.2 years before parous women. The study, which analyzed data from over 500 women, also found that nulliparous women have a higher educational level and may possess a lower disposition to developing arthritis.
A new EULAR study found that patients with elevated MRP8/14 levels are at increased risk of relapse after methotrexate withdrawal. The study suggests that tracking biomarker levels may help predict treatment responses in JIA patients.
A study found that ultrasound significantly changed management decisions for 50% of patients with rheumatic hand and foot conditions. Ultrasound increased certainty in clinical findings, ranging from 24% to 56%, and led to a decrease in the use of disease-modifying anti-rheumatic drugs (DMARDs) for difficult-to-assess patients.
A survey of 2,400 practicing clinicians found that only 65% were aware of at least one major clinical trial on complementary and alternative medicine (CAM) therapies. Clinicians who were aware of CAM trials reported greater ability to interpret evidence and acceptance of its value.
The guidelines aim to ensure physicians worldwide are aware of available treatments for patients with psoriatic arthritis. Newer medications inhibiting tumor necrosis factor (TNF) are recommended for consideration.
Rheumatoid arthritis incidence and prevalence are on the rise among women in the US, with a 54% increase in female cases from 36 to 54 per 100,000 annually, according to a Mayo Clinic study. Researchers believe an environmental factor may be contributing to this trend, which could indicate a need for further research.
The new guidelines update strategies for treating rheumatoid arthritis with a focus on preventing joint damage and disability. The recommendations include the use of methotrexate or leflunomide therapy, as well as anti-TNF agents in combination with these therapies.
A study found that abatacept reduced flare events and improved symptoms in children with juvenile idiopathic arthritis, but its design raised questions about its true effectiveness. The treatment was well-tolerated, but the study's limitations highlighted the need for further research to establish its role in treating this condition.
Adalimumab therapy shows promise in treating ankylosing spondylitis, rheumatoid arthritis, and psoriatic arthritis patients who have failed other treatments. After 12 weeks of treatment, AS patients experienced a mean reduction in BASDAI of -2.4, while RA patients showed a mean reduction in DAS28 of -1.9.
A systematic step-up DMARD treatment schedule led to remission in 38.8% of early RA patients at week 24 and 52.1% at week 36. The researchers achieved these results through a tightly regulated treatment scheme involving methotrexate, sulfasalazine, adalimumab, and other medications.
A recent study found that general practitioners diagnosed 79% of rheumatoid arthritis cases, but only 27% of those cases were referred to a rheumatologist. Furthermore, many patients were not even confirmed to have rheumatoid arthritis despite being seen by a specialist in the first three months after diagnosis.
Patients with rheumatoid arthritis are at a higher risk of developing depression due to chronic pain and functional disability. Only one in five RA patients discuss their symptoms with their rheumatologists, highlighting the need for improved communication about mental health.
A study of rheumatoid arthritis patients found that almost 11% experienced moderate to severe depression symptoms. Patients who were restricted in their activities were more likely to have these symptoms, and few discussed their condition with their rheumatologists.
Geisinger's rheumatology department redesigned osteoporosis and rheumatoid arthritis care by simplifying the ordering process for bone density scans. As a result, 88% of patients received the scan, compared to 18% previously, with quadrupling the number of patients who underwent testing.
Researchers evaluated mycophenolate mofetil to reduce lupus flares in SLE patients and found significant reductions, especially for severe flares. The treatment was effective even with reduced use of anti-inflammatory drug prednisone.
Research at University of Bath finds fibromyalgia pain caused by a mismatch between sensory and motor systems. The study suggests that confusing the brain's sensory-motor systems can exacerbate symptoms, and may even trigger pain flares.
Researchers at the University of Texas Health Science Center at Houston have identified two genes, ARTS1 and IL23R, that contribute to the development of ankylosing spondylitis, a chronic and disabling form of arthritis. This discovery is expected to lead to new therapies and potentially allow for early identification of patients at risk.
Researchers at the University of Pittsburgh School of Medicine are conducting a worldwide study on treating myositis, a rare autoimmune disorder. The study will evaluate the effectiveness of rituximab in improving symptoms of dermatomyositis and polymyositis, with 202 participants from North America and Europe involved.
Researchers found a genetic link between high levels of interferon-alpha and an increased risk of developing lupus. The study suggests that individuals with high interferon-alpha levels may be more likely to develop the disease, especially if triggered by environmental factors.
A study by USF Health found that rheumatologists consistently rate their patients' functional disability higher than the patients themselves, particularly in advanced stages of the disease. The researchers used the Stanford Health Assessment Questionnaire-Disability Index (HAQ-DI) and evaluated 223 patients, finding that rheumatologist...
A study published at EULAR 2007 found that longer-term breastfeeding is associated with a lower risk of developing rheumatoid arthritis in mothers. The study, which involved 136 women with RA and 544 controls, suggested that naturally-induced hormones during breastfeeding may offer protective benefits against the disease.
Researchers tracked 172 patients with hand osteoarthritis for two years, showing a significant increase in pain intensity and functional limitations. Radiological progression was also detected in 20% of subjects, highlighting the need for early intervention to prevent irreversible progression.
Preliminary results show that 59% of patients receiving certolizumab pegol 200mg plus methotrexate achieved a 20% improvement in symptoms after 24 weeks, compared to 14% for those taking methotrexate alone. The treatment combination also resulted in higher ACR70 responses and lower discontinuation rates due to adverse events.
A study of 1041 RA patients found obese participants reported significantly increased ratings for pain and fatigue compared to normal weight counterparts. Obese patients also experienced worse physical functioning, with lower overall quality of life assessments.